Cargando…

M46. THE STUDY OF HEART RATE VARIABILITY AND EMOTIONAL RESPONSE TO POSITIVE AND NEGATIVE AUDIOVISUAL STIMULATION IN PATIENTS WITH SCHIZOPHRENIA

BACKGROUND: This study was to investigate the Heart Rate Variability (HRV) and emotional response to positive and negative audiovisual stimulation in patients with chronic schizophrenia and healthy control group. METHODS: Among 253 chronic schizophrenic patients, 104 patients were informed about thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Seung-Ho, Bahk, Won-Myong, Kwon, Young-Joon, Yoon, Bo-Hyun, Lee, Kwanghun, Kim, Moon-Doo, Nam, Beomwoo, Lee, Sang-Yeol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session II
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233897/ http://dx.doi.org/10.1093/schbul/sbaa030.358

Ejemplares similares

M185. THE EFFECTS OF GROUP ARTS THERAPY BASED ON EMOTION MANAGEMENT TRAINING ON THE EMOTIONAL EXPRESSION, ALEXITHYMIA, DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA
por: Lim, Eunsung, et al.
Publicado: (2020)

F223. COMPARATIVE STUDY OF HEART RATE VARIABILITY AND EMOTIONAL RESPONSE TO POSITIVE AND NEGATIVE AUDIOVISUAL STIMULATION IN PATIENTS WITH CHRONIC SCHIZOPHRENIA AND HEALTHY CONTROL
por: Lee, Sang-Yeol, et al.
Publicado: (2018)

T77. ASSOCIATION BETWEEN INTRACELLULAR INFECTIOUS AGENTS AND SCHIZOPHRENIA
por: Kwon, Young-Joon, et al.
Publicado: (2020)

M135. DEVELOPMENT OF VISUAL SCANPATH PATTERN ANALYSIS BASED ON FACIAL EMOTION PERCEPTION ENHANCEMENT TRAINING PROGRAM IN SCHIZOPHRENIA PATIENTS
por: Nam, Beomwoo, et al.
Publicado: (2020)

T75. METABOLIC SYNDROME AND HEAR RATE VARIABILITY IN SCHIZOPHRENIC INPATIENTS
por: Yoon, Bo-Hyun, et al.
Publicado: (2020)

S216. CASE REPORT OF TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME IN CHILD ADOLESCENT
por: Doo Kim, Moon, et al.
Publicado: (2020)

F115. INSIGHT AND MANIC SYMPTOMS IN PATIENTS WITH CHRONIC SCHIZOPHRENIA IN THE KOREAN COMMUNITY
por: Jon, Duk-In, et al.
Publicado: (2018)

F194. ASSOCIATION STUDY BETWEEN TREATMENT RESPONSE OF AMISULPRIDE AND DOPAMINE D3 RECEPTOR GENE POLYMORPHISMS
por: Lee, Kwanghun, et al.
Publicado: (2018)

T116. CAFFEINE-INDUCED PSYCHIATRIC MANIFESTATIONS
por: Lee, Kwanghun, et al.
Publicado: (2018)

T251. THE STUDY OF QUALITY OF LIFE AND A GLOBAL FUNCTIONING FOR THE SCHIZOPHRENIA PATIENTS IN COMMUNITY BY THEIR RESIDENTIAL ENVIRONMENT
por: Lee, Sang-Yeol, et al.
Publicado: (2018)

S7. NEOSENSITIZATION TO MULTIPLE DRUGS FOLLOWING DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS SYNDROME (DRESS)
por: Kim, Moon Doo, et al.
Publicado: (2018)

S220. BLONANSERIN AUGMENTATION IN PATIENTS WITH SCHIZOPHRENIA – WHO IS BENEFITED FROM BLONANSERIN AUGMENTATION? AN OPEN-LABEL, PROSPECTIVE, MULTI-CENTER STUDY
por: Bahk, Won-Myong, et al.
Publicado: (2018)

S196. ASSOCIATION BETWEEN INTRACELLULAR INFECTIOUS AGENTS AND SCHIZOPHRENIA IN KOREA
por: Kwon, Young-Joon, et al.
Publicado: (2018)

M237. EMOTIONAL INTELLIGENCE AND QUALITY OF LIFE IN SCHIZOPHRENIA AND BIPOLAR-I-DISORDER
Publicado: (2020)

M74. FACIAL EMOTION RECOGNITION ABILITY IN PATIENTS WITH SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS
por: Kjellenberg, Elin, et al.
Publicado: (2020)

Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2019)

M161. NEURAL CHANGES INDUCED BY ELECTROCONVULSIVE THERAPY (ECT) IN SCHIZOPHRENIA PATIENTS: A SYSTEMATIC REVIEW
por: Moon, Sun-Young, et al.
Publicado: (2020)

M227. AN EXPLORATORY STUDY OF AUTOMATED LINGUISTIC ANALYSIS OF SOCIAL NARRATIVES IN SCHIZOPHRENIA
por: Baxter, Tatiana, et al.
Publicado: (2020)

T15. MISMATCH NEGATIVITY INDICES AS A PROGNOSTIC FACTOR FOR REMISSION IN SCHIZOPHRENIA
por: Shim, Se-Hoon, et al.
Publicado: (2020)

M4. CHILDHOOD TRAUMA, BRAIN STRUCTURE AND EMOTION RECOGNITION IN SCHIZOPHRENIA AND HEALTHY ADULTS: A MODERATED MEDIATION ANALYSIS
por: Rokita, Karolina, et al.
Publicado: (2020)

M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Griffiths, Kira, et al.
Publicado: (2020)

M117. ELUCIDATING ARCHITECTURE OF NEGATIVE SYNDROME IN SCHIZOPHRENIA
por: San Ang, Mei, et al.
Publicado: (2020)

M67. UNDERSTANDING SOCIAL COGNITION IN SCHIZOPHRENIA THROUGH THE LENS OF SCHIZOTYPY
por: Lee, Sara-Ann, et al.
Publicado: (2020)

T219. THE ROLE OF MELATONIN AND MELATONIN AGONISTS IN COUNTERACTING ANTIPSYCHOTIC-INDUCED METABOLIC SIDE EFFECTS: A SYSTEMATIC REVIEW
por: Bahk, Won-Myong, et al.
Publicado: (2018)

M215. FACTORS ASSOCIATED WITH CLOZAPINE RESPONSE AND RESISTANCE IN SCHIZOPHRENIA
por: Lee, Jimmy, et al.
Publicado: (2020)

S110. THE CLINICAL IMPLICATION OF CLINICIAN-RATED DIMENSIONS OF PSYCHOSIS SYMPTOM SEVERITY (CRDPSS) FOR DIAGNOSIS BY DSM-5
por: Nam, Beomwoo, et al.
Publicado: (2018)

M222. SURVEY RESULTS FROM TURKEY: KNOWLEDGE ABOUT SCHIZOPHRENIA, PUBLIC STIGMA AND DISCRIMINATION BECAUSE OF SCHIZOPHRENIA
por: Haldun, Soygur, et al.
Publicado: (2020)

M231. INTERNALIZED STIGMA AS A PREDICTOR OF EMPLOYMENT STATUS IN PATIENTS WITH SCHIZOPHRENIA
por: Yi Sum, Min, et al.
Publicado: (2020)

F45. THE EFFICACY AND SAFETY OF BLONASERIN AFTER SWITCHING FROM OTHER ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC INPATIENTS: AN OPEN-LABEL, MULTI-CENTER TRIAL
por: Yoon, Bo-Hyun, et al.
Publicado: (2018)

M73. DRIVING ABILITIES IN PATIENTS WITH SCHIZOPHRENIA
por: Pardeller, Silvia, et al.
Publicado: (2020)

M190. USE OF NULL PRONOUNS IN SCHIZOPHRENIA
por: Chaves, Monica, et al.
Publicado: (2020)

M168. CLINICAL-ANATOMICAL PHENOTYPES OF SCHIZOPHRENIA
por: Kirschner, Matthias, et al.
Publicado: (2020)

M109. WEIGHT GAIN AND THE PATHOPHYSIOLOGY OF SCHIZOPHRENIA
Publicado: (2020)

M216. ASSOCIATIONS OF EXTRAPYRAMIDAL SYMPTOMS WITH PSYCHOTIC SYMPTOMS IN A COHORT OF HOMELESS OR PRECARIOUSLY HOUSED PERSONS WITH OR WITHOUT SCHIZOPHRENIA
por: Kim, David, et al.
Publicado: (2020)

M64. ADDRESSING THE ROLE OF TIMING ON COGNITION IN SCHIZOPHRENIA
por: Alústiza, Irene, et al.
Publicado: (2020)

M245. AN RCT PROTOCOL OF HYBRID-ECT FOR SCHIZOPHRENIA
por: Rong, Han
Publicado: (2020)

M198. INVESTIGATIONAL DOPAMINE ANTAGONISTS FOR THE TREATMENT OF SCHIZOPHRENIA
Publicado: (2020)

M106. VIRTUAL-REALITY COGNITIVE TRAINING AND ASSESSMENT IN SCHIZOPHRENIA
por: Porffy, Lilla, et al.
Publicado: (2020)

M55. STRUCTURAL CHANGES RELEVANT TO MUSICAL DEFICITS IN SCHIZOPHRENIA
por: Sawada, Ken, et al.
Publicado: (2020)

M228. THE EFFECT OF SOCIALIZATION ON ANTICIPATORY AND CONSUMMATORY PLEASURE IN SCHIZOPHRENIA
por: Merchant, Jaisal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h5utvv10uv51907sd6s21em1ul